State Key Laboratory of Bioactive Substances and Functions of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
J Alzheimers Dis. 2012;29(2):379-91. doi: 10.3233/JAD-2011-111577.
L-3-n-butylphthalide (L-NBP), an extract from seeds of Apium graveolens Linn (Chinese celery), has been shown to have neuroprotective effects on cerebral ischemic, vascular dementia and amyloid-β (Aβ)-induced animal models by inhibiting oxidative injury, neuronal apoptosis and glial activation, regulating amyloid-β protein precursor (AβPP) processing and reducing Aβ generation. The aim of the present study was to examine the effect of L-NBP on learning and memory in AβPP and presenilin 1 (PS1) double-transgenic AD mouse model (AβPP/PS1) and the mechanisms of L-NBP in reducing Aβ accumulation and tau phosphorylation. Twelve-month old AβPP/PS1 mice were given 15 mg/kg L-NBP by oral gavage for 3 months. L-NBP treatment significantly improved the spatial learning and memory deficits compared to the vehicle-treated AβPP/PS1 mice, whereas L-NBP treatment had no effect on cerebral Aβ plaque deposition and Aβ levels in brain homogenates. However, we found an L-NBP-induced reduction of tau hyperphosphorylation at Ser199, Thr205, Ser396, and Ser404 sites in AβPP/PS1 mice. Additionally, the expressions of cyclin-dependent kinase and glycogen synthase kinase 3β, the most important kinases involved in tau phosphorylation, were markedly decreased by L-NBP treatment. The effects of L-NBP on decreasing tau phosphorylation and kinases activations were further confirmed in neuroblastoma SK-N-SH cells overexpressing wild-type human AβPP695 (SK-N-SH AβPPwt). L-NBP shows promising candidate of multi-target neuronal protective agent for the treatment of Alzheimer's disease.
L-3-正丁基苯酞(L-NBP)是从芹菜籽中提取的一种物质,已被证明具有神经保护作用,可通过抑制氧化损伤、神经元凋亡和神经胶质细胞激活,调节淀粉样前体蛋白(AβPP)处理和减少 Aβ生成,对脑缺血、血管性痴呆和淀粉样β(Aβ)诱导的动物模型发挥作用。本研究旨在探讨 L-NBP 对 AβPP 和早老素 1(PS1)双转基因 AD 小鼠模型(AβPP/PS1)学习记忆的影响及其减少 Aβ 累积和 Tau 磷酸化的机制。12 月龄 AβPP/PS1 小鼠经灌胃给予 15mg/kg L-NBP 治疗 3 个月。与载体处理的 AβPP/PS1 小鼠相比,L-NBP 治疗显著改善了空间学习和记忆缺陷,而 L-NBP 治疗对脑内 Aβ 斑块沉积和脑匀浆中 Aβ 水平没有影响。然而,我们发现 L-NBP 可诱导 AβPP/PS1 小鼠 Tau 蛋白 Ser199、Thr205、Ser396 和 Ser404 位点过度磷酸化减少。此外,L-NBP 治疗可显著降低参与 Tau 磷酸化的最重要激酶——周期蛋白依赖性激酶和糖原合成酶激酶 3β的表达。L-NBP 降低 Tau 磷酸化和激酶活性的作用在过表达野生型人 AβPP695 的神经母细胞瘤 SK-N-SH 细胞(SK-N-SH AβPPwt)中进一步得到证实。L-NBP 可能是治疗阿尔茨海默病的多靶点神经保护剂的候选药物。